JSAM
PRAX icon

J. Safra Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

J. Safra Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
61
+7
+13% +$2.22K ﹤0.01% 323
2026
Q1 		$17.4K Buy
54
+36
+200% +$11.1K ﹤0.01% 318
2025
Q4 		$5.3K Buy
+18
New +$3.35K ﹤0.01% 414

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

J. Safra Asset Management's PRAX Position: Q2 2026 in Review

J. Safra Asset Management increased its Praxis Precision Medicines (PRAX) stake by 13% in Q2 2026, buying an estimated $2.22K and bringing the position to 61 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

J. Safra Asset Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • J. Safra Asset Management held 61 shares of Praxis Precision Medicines worth $20.4K as of Q2 2026.
  • J. Safra Asset Management bought 7 Praxis Precision Medicines shares in Q2 2026, an estimated $2.22K.
  • Praxis Precision Medicines made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #323 holding.
  • J. Safra Asset Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.